XTX Topco’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Buy
42,918
+32,133
+298% +$875K 0.02% 1641
2026
Q1
$299K Buy
+10,785
New +$308K 0.01% 2483
2025
Q4
Sell
-12,806
Closed -$328K 3307
2025
Q3
$328K Buy
+12,806
New +$281K 0.02% 1441
2024
Q1
Sell
-3,454
Closed -$34K 1823
2023
Q4
$34K Buy
3,454
+1,351
+64% +$12.8K 0.01% 1293
2023
Q3
$22.3K Buy
+2,103
New +$25.3K ﹤0.01% 1362
2022
Q3
Sell
-1,101
Closed -$28K 1095
2022
Q2
$28K Buy
+1,101
New +$25.3K 0.01% 795
2022
Q1
Sell
-2,035
Closed -$57K 668
2021
Q4
$57K Buy
+2,035
New +$66.7K 0.03% 551
2021
Q2
Sell
-954
Closed -$53K 800
2021
Q1
$53K Buy
+954
New +$63.2K 0.03% 618

Other funds holding ASMB

XTX Topco's ASMB Position: Q2 2026 in Review

XTX Topco increased its Assembly Biosciences (ASMB) stake by 298% in Q2 2026, buying an estimated $875K and bringing the position to 42,918 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #1641.

XTX Topco first reported a position in ASMB in Q1 2021 and has held it in 8 quarters since. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • XTX Topco held 42,918 shares of Assembly Biosciences worth $1.18M as of Q2 2026.
  • XTX Topco bought 32,133 Assembly Biosciences shares in Q2 2026, an estimated $875K.
  • Assembly Biosciences made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1641 holding.
  • XTX Topco first reported a position in Assembly Biosciences in Q1 2021 and has held it in 8 quarters since.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.